cp wire

CP Wire Articles

Inflammatix Named a Finalist in Fast Company's 2018 World Changing Ideas Awards for Its Novel HostDx Tests

Inflammatix announced today that it has been named a finalist in Fast Company's 2018 World Changing Ideas Awards for its novel HostDx tests, which read the immune system to tackle the global... read more

Tue, 04/10/18 - 09:27 am
FDA Requires More Time to Review Abbvie and Neurocrine Endometriosis Drug Elagolix


AbbVie and Neurocrine announced notification by the U.S. Food and Drug Administration (FDA) that it requires extended time to review additional information regarding the results of liver... read more

Tue, 04/10/18 - 09:14 am
vTv therapeutics Alzheimer's Drug Fails to Reach Primary Endpoints in Ph III study

vTv (Nasdaq:VTVT) today announced that results from Part A of the Company’s Phase 3 STEADFAST study of the investigational medication azeliragon in people with mild Alzheimer’s disease did not... read more

Mon, 04/9/18 - 08:21 pm
Innovation Pharmaceuticals Reports on Successful Phase II Trial of Brilacidin-OM for Oral Mucositis

Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report further data analysis from its successfully completed Phase 2 clinical... read more

Mon, 04/9/18 - 03:14 pm
The Great Drive to Develop Treatments for NASH continues with Second Genome Presenting Data Supporting Development of Its P2X7 Inhibitor, SGM-1019

Second Genome, Inc., a leader in the development of novel medicines derived from the human microbiome, today announced the presentation of preclinical data and results from a Phase 1 study in... read more

Mon, 04/9/18 - 03:12 pm

Pages